Portolan Capital Management, LLC Catalent, Inc. Transaction History

Portolan Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $783,224 - $1.22 Million	10,824 Added 16.91%	74,842 $5.42 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $2 Million - $2.62 Million	-22,943 Reduced 26.38%	64,018 $6.87 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $8.19 Million - $10.8 Million	86,961 New	86,961 $9.64 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Portolan Capital Management, LLC with notifications on news.